IVF add-on may be expensive, invasive, and ineffective, study finds

One of the most common add-ons to IVF procedures undertaken in Australia and globally by infertile couples may be a waste of time as well as expensive and invasive, and may even reduce the chances of success, according to a new report in The Lancet.

Survey reveals alarming dental decay rates in Kentucky preschoolers

The University of Kentucky College of Dentistry’s 2023 Kentucky Early Learners’ Oral Health Surveillance Project survey found dental decay rates for Kentucky children ages 2

November 8, 2024

VC struggles, drug pricing negotiations, & Novo’s abrupt Wegovy decision

Why did Novo Nordisk pull its paperwork to expand the use of Wegovy for a common type of heart failure? How will we know if

August 8, 2024

FDA declines to grant Amgen’s Lumakras full approval in lung cancer after negative advisory committee vote

The FDA rejected Amgen’s bid to convert Lumakras’ accelerated approval into a full approval in lung cancer, the biopharma company announced Tuesday morning, and has

December 27, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.